COMPANY PROFILE

Prognos

Explore full profile

Improving Health by Predicting Disease

New York City, United StatesFounded 2010Biotech & Life Sciences

Valuation $0–100M Latest valuation · 2023

Headcount <100 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About Prognos

An AI-powered predictive healthcare platform specializing in early disease detection and personalized risk assessment. By analyzing complex medical data, the company collaborates with payers, life sciences, and diagnostics companies to drive earlier decisions in healthcare. The platform utilizes advanced data interpretation and strategic planning capabilities to enhance decision-making for its clients, which include organizations in the healthcare sector.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2010
Headquarters: New York City, United States
Employees: 56
Open positions: None listed
Dealroom signal: 66.3/100
Industry: Health, Enterprise Software
Sub-industry: BioTechnology, Health Platform
Sector: Biotech & Life Sciences, Biotechnology, Hard Tech, DT and LS, science-based
Technology: Artificial Intelligence, Deep Tech, Machine Learning
Business model: SaaS
Client focus: b2b, b2c
Investment activity: 2 companies, latest Sep 2013
Capital deployed: —
Preferred round: ACQUISITION
Links: Website LinkedIn X

Latest news

Press, funding announcements and product moves mentioning Prognos.

See all news

Funding history

5 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
LATE VCOther financing	May 2023	$23M	$93M	LabCorp · Safeguard Scientifics · Merck Global Health Innovation Fund · Hikma Ventures	↗
SERIES COther financing	Nov 2017	$21M	$82M	Cigna Group · Hermed Capital · Safeguard Scientifics · Hikma Ventures	—

Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Prognos website traffic

Latest recorded traffic for Prognos is 490 monthly website visits, up 226.7% over the last three months. Prognos's team declined 5.1% over the past year.

Latest monthly visits490 3-month web change+226.7% 1-year team growth-5.1%

Monthly website visitsOct 2017–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
HUHurdleIs an AI driven platform unlocking the power of epigenetics for personalized healthcare	London, United Kingdom	Operational	58	$1.5M	$5.8M
OMOmicsChartPatient-centric cancer data and analytics platform for translational cancer biologists	Cardiff, United Kingdom	Operational
QIQMENTA IMAGINGQMENTA is on a mission to help make brain diseases a thing of the past by using imaging to its full potential with computational analytics	El Masnou, Spain	Operational
TETemedicaHealth insights ecosystem for real-world evidence	Munich, Germany	Operational
BEBehold.aiAI-powered diagnostic platform for medical imaging analysis	London, United Kingdom	Operational
ENEnliticA modern machine learning company dedicated to revolutionizing diagnostic healthcare	San Francisco, United States	Operational
ICIcometrixAI-powered software for quantitative brain scan analysis	Leuven, Belgium	Acquired
UGUgenTecData analytics software for lab technicians	Hasselt, Belgium	Acquired